Autoantibodies against oxidized low-density lipoprotein correlate with Achilles tendon xanthomas

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 6, 2000, Pages 501-506

  Okada, M ^a   Miida, T ^a   Fujiwara, A ^a   Inomata, N ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Achilles tendon xantoma; Atherosclerosis; Autoantibody; Hyperlipidemia; Oxidized low density lipoprotein

Indexed keywords

ANTIGEN; AUTOANTIBODY; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACHILLES TENDON; ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SERUM; SPECTROPHOTOMETRY; XANTHOMA;

EID: 0033900397     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.073     Document Type: Article

References (32)

1. Atherosclerosis and autoimmunity
2. Autoantibodies against oxidized low density lipoprotein: A review of clinical findings and assay methodology
3. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk
4. Antibody against oxidized low-density lipoprotein predicting myocardial infarction
5. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
6. LDL oxidation in patients with severe carotid atherosclerosis, a study of in vitro and in vivo oxidation markers
7. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL
8. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: A biochemical signature of an enhanced in vivo low-density lipoprotein oxidation
9. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis
10. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM
11. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
12. ELISA of IgG antibody to oxidized low-density lipoprotein: Effects of blocking buffer and method of data expression
13. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers
14. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease
15. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls
16. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty
17. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus
18. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis, a case-control study
19. Toxicity of oxygenated cholesterol derivatives toward cultured human umbilical vein endothelial cells
20. Modifications of low-density lipoprotein that increase its atherogenicity
21. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines, evidence implicating the lipid moiety of the lipoprotein as the binding site
22. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
23. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
24. Plasma lipoproteins: Apolipoprotein structure and function
25. Increased autoantibody titers against epitopes on oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis
26. Cholesterol synthesis by human fibroblasts in the presence of LDL and anti-LDL IgA
27. Immune complexes of LDL induce atherogenic responses in human monocytic cells
28. Autoantibodies against oxidized low density lipoproteins (oxLDL): Characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL
29. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
30. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity
31. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
32. Hyperimmunization of apo-E-deficit mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis